13-cis-Acitretin
Modify Date: 2024-01-14 18:27:43
13-cis-Acitretin structure
|
Common Name | 13-cis-Acitretin | ||
|---|---|---|---|---|
| CAS Number | 69427-46-9 | Molecular Weight | 326.429 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 521.3±38.0 °C at 760 mmHg | |
| Molecular Formula | C21H26O3 | Melting Point | 228-230ºC | |
| MSDS | N/A | Flash Point | 180.3±20.3 °C | |
Use of 13-cis-AcitretinIsoacitretin is an oral retinoid effective in the treatment of psoriasis. |
| Name | 13-cis Acitretin |
|---|---|
| Synonym | More Synonyms |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 521.3±38.0 °C at 760 mmHg |
| Melting Point | 228-230ºC |
| Molecular Formula | C21H26O3 |
| Molecular Weight | 326.429 |
| Flash Point | 180.3±20.3 °C |
| Exact Mass | 326.188202 |
| PSA | 46.53000 |
| LogP | 5.73 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.570 |
| Storage condition | Amber Vial, -80°C Freezer |
| RIDADR | NONH for all modes of transport |
|---|
|
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
J. Am. Acad. Dermatol. 71(6) , 1167-75, (2014) The effectiveness of psoriasis therapies in real-world settings remains relatively unknown.We sought to compare the effectiveness of less commonly used systemic therapies and commonly used combination... |
|
|
Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
Pharmazie 68(6) , 449-52, (2013) The present study aimed to evaluate the potential risk of drug-drug interactions associated with acitretin which is a drug for therapy of psoriasis approved by the Food and Drug Administration (FDA). ... |
|
|
IgA pemphigus: case series with emphasis on therapeutic response.
J. Am. Acad. Dermatol. 70(1) , 200-1, (2014)
|
| Soriatane |
| 9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid |
| 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid |
| (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid |
| (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid |
| 9-(4-Isopropyl-phenyl)-guanin |
| Neo-Tigasone |
| Acetretinate |
| 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)- |
| (all-E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid |
| Neotigason |
| 2-amino-9-(4-isopropyl-phenyl)-1,9-dihydro-purin-6-one |
| Acitretin |
| 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)- |
| (2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid |
| all-trans-acitretin |
| SNGP-201-04-E06 |